Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2022.2082946
Abstract: ABSTRACT Introduction Several patients with myasthenia gravis (MG) do not adequately respond to available drugs or exhibit poor tolerance, necessitating the need for new therapies. Areas covered The paper discusses the rapidly evolving target-specific immunotherapies… read more here.
Keywords: myasthenia gravis; complement anti; complement; complement therapeutics ... See more keywords